Last reviewed · How we verify
Bharat Serums and Vaccines Limited — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Amphotericin B Lipid emulsion | Amphotericin B Lipid emulsion | phase 3 | Polyene antifungal | Ergosterol | Infectious Disease |
Therapeutic area mix
- Infectious Disease · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 1 shared drug class
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · 1 shared drug class
- Dr. Falk Pharma GmbH · 1 shared drug class
- Drugs for Neglected Diseases · 1 shared drug class
- Federal University of Health Science of Porto Alegre · 1 shared drug class
- Fundacion Nacional de Dermatologia · 1 shared drug class
- Pfizer · 1 shared drug class
- Poitiers University Hospital · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Bharat Serums and Vaccines Limited:
- Bharat Serums and Vaccines Limited pipeline updates — RSS
- Bharat Serums and Vaccines Limited pipeline updates — Atom
- Bharat Serums and Vaccines Limited pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Bharat Serums and Vaccines Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bharat-serums-and-vaccines-limited. Accessed 2026-05-17.